Blog

The global market for Alogliptin, a widely used DPP-4 (dipeptidyl peptidase-4) inhibitor in diabetes management, is poised for significant growth by 2025. Driven by an increasing prevalence of type 2 diabetes, advancements in pharmaceutical innovation, and expanding healthcare accessibility, this market is expected to achieve steady expansion in the coming years. Key Market Drivers Rising

Why are tyrosne kinase inhibitors so effective for cancer? Tyrosine kinase inhibitors （TKIs） have become a groundbreaking treatment option in the fight against cancer. Known for their targeted approach, TKIs work by inhibiting the activity of tyrosine kinases – enzymes that play a key role in cell signaling pathways. In many cancers, mutations cause these

How to export pharmaceutical products outside the country?           Exporting pharmaceutical products requires a careful understanding of regulatory requirements, quality standards, and international trade laws. Here’s a general guide on the steps: 1. Market Research and Target Country Regulations Identify Target Markets: Start by researching the demand and regulatory requirements of

       India, often called the “pharmacy of the world,” plays a crucial role in global healthcare by producing a substantial portion of the world’s generic medicines. However, despite its manufacturing prowess, India depends heavily on China for the Active Pharmaceutical Ingredients (APIs) that serve as the essential building blocks for these drugs. Approximately

What Are APIs (Active Pharmaceutical Ingredients)? When it comes to pharmaceuticals, the term API (Active Pharmaceutical Ingredient) is one of the most critical yet often misunderstood concepts. APIs are the backbone of any drug formulation, playing a central role in the treatment of various medical conditions. In this blog, we’ll break down the essential details

       FMI has projected East Asia hold more than thirty percent markets share through the course of the forecast period. Growth within the region is likely to be spearheaded by China. As per FMI, the China pharmaceutical intermediates market is estimated to surpass US$ 7 Bn in 2021, exhibiting a CAGR of 6%

   In the pharmaceutical industry, the terms Active Pharmaceutical Ingredient (API) and pharmaceutical intermediates are crucial for understanding drug development and production. While they may seem similar, they play distinct roles in the manufacturing process. **What are APIs?** Active Pharmaceutical Ingredients (APIs) are the biologically active components in medications responsible for the intended therapeutic effects.

Pharmaceutical intermediates are essential chemical compounds synthesized as part of the process of producing Active Pharmaceutical Ingredients (APIs). These intermediates act as foundational components, undergoing a series of chemical reactions, purifications, isolations, and transformations before resulting in the final pharmaceutical products (FPPs). Common examples of pharmaceutical intermediates include amino acids, boronic acid, ylides, benzophenones, and